Skip to main content
. 2017 Nov 7;20(10):1683–1691. doi: 10.1093/europace/eux331

Table 1.

Characterization of treatment groups at baseline,

Groups
Variables Conservative (Con) Pacing Myectomy (Mye) P-value
Con vs. pacing Con vs. mye Pacing vs. mye
n (Female %) 121 (48) 88 (52) 42 (45) 0.57 0.22 0.45
Age at diagnosis (years)
 Mean ± SD 53.9 ± 20.6 55.3 ± 18.3 32.1 ± 23.0
 Median (IQR) 59.0 (23.0) 59.0 (23.0) 34.4 (40.0) 0.872 <0.001 <0.001
Post-diagnosis FU (years)
 Mean ± SD 11.3 ± 7.5 16.4 ± 8.4 19.2 ± 10.2
 Median (IQR) 9.5 (9.1) 14.5 (12.9) 16.3 (16.8) <0.001 <0.001 0.131
NYHA class
 Mean ± SD 2.1 ± 0.8 2.3 ± 0.6 2.0 ± 0.8
 Median (IQR) 2 (1) 2 (1) 2 (1) 0.350 0.242 0.050
Beta-blocker therapy, n (%) 88 (73) 59 (67) 32 (76) 0.375 0.830 0.206
Metoprolol dose (mg/day)a 200 (200) 100 (100) 100 (125) 0.017 0.006 0.174
Verapamil/diltiazem, n (%) 14 (12) 14 (16) 3 (7) 0.363 0.920 0.153
LVOT gradient (mmHg) 61 (54) 64 (66) 73 (64) 0.663 0.048 0.149
LVOT gradient >50 mmHg, n (%) 73 (58) 60 (68) 34 (79) 0.128 0.013 0.194
Septum (mm) , n (%) 18 (5) 20 (5) 18 (7) 0.031 0.429 0.051
Posterior LV wall (mm), n (%) 12 (3) 13 (3) 12 (5) 0.147 0.772 0.527
LVEDD (mm), n (%) 43 (9) 46 (10) 42 (7) 0.047 0.233 0.021
LAD (mm), n (%) 40 (9) 44 (13) 40 (11) <0.001 0.762 0.013
LVEF (%), n (%) 69 (15) 69 (16) 68 (16) 0.665 0.651 0.651

Values are represented as median (IQR) where not otherwise specified. P-values: Mann–Whitney U test (inter-group) and χ2 test (categorical variables).

Con, Conservative, medical therapy only; FU, follow-up; IQR, interquartile range; LAD, left atrium diameter; LV, left ventricle; LVEDD, left ventricle end-diastolic diameter; LVEF, left ventricular ejection fraction; LVOT, left ventricular outflow tract; n, number; NYHA, New York Heart Association Class; SD, standard deviation.

a

Metoprolol was the most common beta-blocker used, and thus doses of other beta-blockers have been converted to metoprolol equivalents. P-values in bold indicate significance.